Abeona (ABEO) CCO Madhav Vasanthavada Sells 4,902 Shares

What Happened
Madhav Vasanthavada, Chief Commercial Officer of Abeona Therapeutics (ABEO), disposed of 4,902 shares in an open‑market sale on September 29, 2026. The weighted‑average sale price was $5.16 per share for total proceeds of approximately $25,273. The filing indicates the shares were sold to cover tax obligations tied to the vesting of restricted stock awards — a routine, tax‑related sale rather than a directional bet on the stock.

Key Details

• Transaction date: 2026-09-29
• Shares sold: 4,902 at a weighted avg price of $5.16; prices in the trades ranged from $5.1150 to $5.3000 (reporting person can provide per‑trade breakdown on request).
• Total proceeds: ~$25,273.
• Reason/footnote: Sale to cover tax obligations associated with vesting of restricted stock awards (F1).
• Filing timeliness: Reported on the same date (file date/period of report 2026-09-29); not indicated as late.
• Shares owned after transaction: Not specified in the provided excerpt of the Form 4.

Context
This was a tax‑related disposition of vested restricted stock (routine administrative sale), not an open‑market purchase that might signal insider confidence. The weighted average price and the disclosed range mean the sale occurred in multiple trades; the filer offered to provide the exact allocation of shares to each price upon request. For retail investors, routine tax withholding sales are typically neutral informationally.